Liminatus Pharma is a preclinical oncology company focused on a CD47 antibody. Check out why I see little reason for ...

From 1990 to 2021, the global burden of musculoskeletal disorders (MSDs) among postmenopausal women (PMW) grew significantly, and 2045 projections indicate this trend will continue, according to a ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic syndromes.